• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Anlon Healthcare Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
544497
INE0Y8W01025
4.0321703
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AHCL
20.46
706.91
EPS(TTM)
Face Value()
Div & Yield %
0.65
2
0
 

Maruti Suzuki clocks 33% YoY jump in April sales; production up 16% YoY
May 02,2026
Total domestic sales (including passenger vehicles, light commercial vehicles and OEM supplies) increased 31.41% to Rs 1,99,592 crore in April 2026, compared with Rs 151,880 crore in April 2025.

Total export sales stood at Rs 40,054 crore in April 2026, up 43.51% compared with Rs 27,911 crore in April 2025.

On the production front, the company’s total output jumped 16.45% to 209,565 units in April 2026 compared with 1,79,956 units produced in April 2025.

Total passenger vehicles production rose 16.58% YoY to 206,097 units while light commercial vehicles production increased 9.33% YoY to 3, 468 units in April 2026 over April 2025.

Maruti Suzuki India is engaged in the manufacture, purchase, and sale of motor vehicles, components, and spare parts (automobiles).

On a standalone basis, net profit declined 6.9% YoY to Rs 3,590.5 crore in Q4 FY26 from Rs 3,857.3 crore in Q4 FY25. Revenue from operations rose 28.9% YoY to Rs 50,078.7 crore in Q4 FY26 compared with Rs 38,839.1 crore a year ago.

The counter rose 0.40% to settle at Rs 13,312.85 on Thursday, 30 April 2026.